GMO Alternative Allocation SPC Ltd.

No prior EDGAR filings from this manager indicate either a first-time fund registration or a manager operating under a different entity name historically; the three-person GP slate and 06b exemption (pre-existing relationships only) suggest a closed founder network raising from established allocators rather than a broad institutional roadshow.

A May 2026 amendment in the post-rate-hike environment reflects either covenant pressure from anchor LPs requesting better terms or a reset to the capital raise timeline after market volatility; filing an amendment rather than closing signals either LP commitments were conditional or the manager is actively managing the raise window.

Verify whether any of the three named GPs—Nasrah, Evans, or Griffiths—have disclosed key-person provisions in the LPA and confirm whether prior versions of this fund existed under a different manager entity name, since the absence of EDGAR history does not rule out predecessor vehicles or side-by-side manages that would affect concentration risk and GP continuity.